Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Longeveron
(NASDAQ:LGVN)
Intraday
$1.65
-0.07
[-4.07%]
After-Hours
$1.65
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.65
-0.07
[-4.07%]
At close: Apr 25
$1.65
0
[0.00%]
After Hours: 7:02PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Longeveron Stock (NASDAQ:LGVN)
Longeveron Stock (NASDAQ: LGVN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 18, 2024
Longeveron Raises A Total Of $11.4M In Gross Proceeds From Warrant Exercise Offering And Public Offering
Benzinga Newsdesk
-
Apr 18, 2024, 4:09PM
Peering Into Longeveron's Recent Short Interest
Benzinga Insights
-
Apr 18, 2024, 12:00PM
Wednesday, April 17, 2024
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
Avi Kapoor
-
Apr 17, 2024, 2:34PM
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 17, 2024, 1:36PM
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
Avi Kapoor
-
Apr 17, 2024, 12:44PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 17, 2024, 12:31PM
Longeveron shares are trading lower after the company announced the exercise of warrants for $6.2 million in gross proceeds.
Benzinga Newsdesk
-
Apr 17, 2024, 10:16AM
Longeveron Announces Exercise Of Warrants For $6.2M Gross Proceeds
Benzinga Newsdesk
-
Apr 17, 2024, 8:16AM
Tuesday, April 16, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Apr 16, 2024, 4:31PM
Watching Longeveron Shares; Zacks Small-Cap Research Sets $15.15 Valuation
Benzinga Newsdesk
-
Apr 16, 2024, 12:49PM
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 15, 2024, 4:31PM
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
Avi Kapoor
-
Apr 15, 2024, 2:30PM
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 15, 2024, 2:11PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Apr 15, 2024, 12:31PM
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
Avi Kapoor
-
Apr 15, 2024, 12:02PM
What's Going On With Longeveron Stock?
Erica Kollmann
-
Apr 15, 2024, 11:58AM
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
Avi Kapoor
-
Apr 15, 2024, 10:00AM
Longeveron shares are trading higher following insider buys from multiple company executives.
Benzinga Newsdesk
-
Apr 15, 2024, 9:16AM
Director, Chief Scientific Officer Joshua Hare Of Longeveron Reported Purchase On Friday Of 297,872 Shares At Average Price Of $1.24
Benzinga Newsdesk
-
Apr 15, 2024, 9:14AM
Director Rock Soffer Of Longeveron Reported Purchase On Friday Of 276,596 Shares At Average Price Of $1.24
Benzinga Newsdesk
-
Apr 15, 2024, 9:12AM
CEO Mohamed Wa'el Ahmed Hashad Of Longeveron Reported Purchase On Friday Of 21,276 Shares At Average Price Of $1.24
Benzinga Newsdesk
-
Apr 15, 2024, 9:05AM
Market-Moving News for April 15th
Benzinga Newsdesk
-
Apr 15, 2024, 8:44AM
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B In Mild Alzheimer's Disease Accepted For Featured Research Session Oral Presentation At 2024 AAIC
Benzinga Newsdesk
-
Apr 15, 2024, 8:32AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 15, 2024, 8:07AM
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 15, 2024, 5:45AM
Monday, April 08, 2024
Gold Moves Higher; Auddia Shares Surge
Avi Kapoor
-
Apr 8, 2024, 2:51PM
Why Longeveron (LGVN) Stock Exploded Higher Today
Henry Khederian
-
Apr 8, 2024, 2:28PM
Longeveron Prices $5.25M Public Offering At $2.35/Share
Benzinga Newsdesk
-
Apr 8, 2024, 2:20PM
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 8, 2024, 1:10PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Apr 8, 2024, 12:31PM
Crude Oil Moves Lower; Perion Network Shares Tumble
Avi Kapoor
-
Apr 8, 2024, 12:12PM
US Stocks Higher; Dow Gains Over 50 Points
Avi Kapoor
-
Apr 8, 2024, 9:45AM
Market-Moving News for April 8th
Benzinga Newsdesk
-
Apr 8, 2024, 8:44AM
Longeveron Issues Letter To Shareholders Highlighting Corporate Strategy, Clinical Pipeline And 2024 Key Priorities And Goals
Benzinga Newsdesk
-
Apr 8, 2024, 8:44AM
Longeveron shares are trading higher after the company submitted paperwork for a share offering.
Luke J Jacobi
-
Apr 8, 2024, 8:29AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 8, 2024, 8:09AM
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 8, 2024, 5:15AM
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 5, 2024, 4:31PM
Thursday, March 28, 2024
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 28, 2024, 8:21AM
Wednesday, March 27, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Mar 27, 2024, 8:55AM
Tuesday, March 26, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Mar 26, 2024, 7:50PM
Wednesday, March 20, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Mar 20, 2024, 1:31PM
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 19, 2024, 5:34PM
Longeveron Board Approves 1-for-10 Reverse Split Of Class A Common Stock
Benzinga Newsdesk
-
Mar 19, 2024, 4:02PM
Tuesday, February 27, 2024
Recap: Longeveron Q4 Earnings
Benzinga Insights
-
Feb 27, 2024, 4:40PM
Longeveron Q4 EPS $(0.25) Misses $(0.21) Estimate, Sales $63.00K Miss $210.00K Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:35PM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Earnings Preview For Longeveron
Benzinga Insights
-
Feb 26, 2024, 4:00PM
Tuesday, February 13, 2024
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
Faith Ashmore
-
Sponsored
Wednesday, February 07, 2024
Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results
Meg Flippin
-
Sponsored
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch